Professional Documents
Culture Documents
Periodontology Pharmacology: Weinberg, Chapter 11
Periodontology Pharmacology: Weinberg, Chapter 11
Weinberg, chapter 11
Learning Objectives
1. Discuss the rationale for the use of chemical agents in the treatment of periodontal diseases 2. Describe the various types of drug delivery systems 3. Understand how to select the optimum intervention for individual clients 4. Research on the internet specific types of controlled release systems 5. Understand the need to stay current regarding use and delivery of chemical agents
select antimicrobial
Reality: evidence based selection In-office testing: takes little time, improves selection knowledge improves outcomes
Costly to client
Client Considerations
1. Site specific or general application 2. Client sensitivity 3. Appropriate follow-up evaluation
Response of tissues Client compliance Name of agent & method of use Anticipated outcomes Side effects
Chlorhexidine
Available CHX (0.12%) products:
Chlorhexidine
Mechanism of action:
Ruptures bacterial cell membrane releases cytoplasm contents Reduces adherence capacity of P.g.
Chlorhexidine
Not all clients exhibit undesirable side effects Side effects may include:
Extrinsic brown staining Increase in supragingival calculus accumulation Alteration in taste perception (temporary) Bitter taste
Mucosal desquamation
Chlorhexidine
Side effects:
Japanese race prone to CHX allergies 30 min. time lapse between rinsing with CHX & rinsing with fluoride (SnF) High alcohol content (11.6%)
Dehydrates mucosa & may intensify pain Increased risk of oropharyngeal cancer (possible)
Chlorhexidine
Use of CHX:
Inhibits dental plaque & gingivitis Full mouth disinfection Oral mucositis Site specific professional irrigation
Home irrigation or rinsing Post-periodontal surgery Some therapeutic value in treating candida infections
Chlorhexidine
Instructions for use:
Rinsing:
15 ml for 30s bid Short term therapy (1-2 weeks up to 3 months)) Professional: 0.12% At-home: 0.06% daily
Irrigation:
Pre-procedural rinse
10 ml for 60s
Chlorhexidine
Clinical efficacy:
Chlorhexidine
Re-assessment:
PerioChip
PerioChip
Description:
Rectangular chip, supplied in boxes of 10 chips Contains 2.5 mg Chlorhexidine D-gluconate Biodegradable matrix of hydrolyzed gelatin Store in refrigerator until use 2 year shelf life
PerioChip
Mechanism of action:
Bactericidal antiseptic agent Binds with tissue no need for surgical dressing Chip gradually biodegrades releasing CHX Sustained release over period of 7-10 days GCF concentrations vary among clients
Peaks at (2-4) hours after insertion Peaks again at approx. 72 hours Concentrations gradually decline over 7-10 day period
PerioChip
Indications:
PerioChip
Recommended dose:
One PerioChip into one periodontal pocket Not recommended to place more than 2 chips around one tooth at one time Can be administered once/3 months (PD 5 mm)
PerioChip
Adverse reactions:
Approx. 40% of teeth associated with chip insertion experience tooth sensitivity dissipates as chip dissolves Slight pressure for 24 hours Mild-moderate swelling, gingival sensitivity Likelihood of reaction increases with repeated administration
PerioChip
Client information:
Brush as usual Avoid flossing around teeth with inserted PerioChip for 10 days Contact dental office if:
No bacterial resistance (studies conducted over 2 year period) No tooth staining or altered taste perception
PerioChip
Administration:
Keep chip refrigerated until ready to use Thorough debridement of area to be treated Irrigate area to flush out debris Dry area Grasp chip with non-serrated cotton pliers Entire chip must be submerged use probe to maneuver chip to pocket base
PerioChip
Clinical efficacy:
Greater PD reduction when chip used in conjunction with debridement Reductions in probing depths reported anywhere from 1.0 mm 2.0 mm or greater
Listerine
1920s ad
Current
Essential Oils
Available products:
Mechanism of action:
Low substantivity Disrupts bacterial cell wall & inhibits bacterial enzyme production
Essential Oils
Side effects:
Carcinogenic potential (insufficient evidence to link oral cancers with mouthrinses containing alcohol)
Slight extrinsic staining Drying effects Temporary burning sensation, unpleasant taste
Essential Oils
Use of Essential Oil mouthrinse:
Anti-plaque & anti-gingivitis 20 ml full strength for 30s bid More frequent use may lead to desquamation of oral tissues
About 50% as effective as CHX Plaque reductions range from 20-40% Gingivitis reductions range from 25-35%
Clinical efficacy:
QAC
Available products:
Scope (P&G) Cepacol (J.B. Williams) Viadent Oral Rinse Advanced Care (Colgate) Oral-B Antiplaque Rinse
QAC
Mechanism of action:
Increased bacterial cell wall permeability (favours lysis) Alatered cell wall metabolism Decreased ability for bacterial to adhere to oral surfaces Low substantivity (about 3 hours)
QAC
Side effects:
QAC
Use of products:
Anti-plaque (up to 14%) Anti-gingivitis (up to 24%) Short term studies only Activity altered by abrasives, flavoring agents